z-logo
Premium
Aqueous Synthesis of Triphenylphosphine‐Modified Gold Nanoparticles for Synergistic In Vitro and In Vivo Photothermal Chemotherapy
Author(s) -
Benyettou Farah,
Ramdas Nair Anjana,
Dho Yaereen,
Prakasam Thirumurugan,
Pasricha Renu,
Whelan Jamie,
Traboulsi Hassan,
Mazher Javed,
Sadler Kirsten C.,
Trabolsi Ali
Publication year - 2020
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.202000216
Subject(s) - hela , aqueous solution , photothermal therapy , colloidal gold , photodegradation , in vivo , biophysics , nanoparticle , triphenylphosphine , chemistry , nuclear chemistry , intracellular , photochemistry , in vitro , materials science , nanotechnology , organic chemistry , biochemistry , catalysis , biology , photocatalysis , microbiology and biotechnology
Abstract Triphenylphosphine (TPP) surface‐functionalized and F‐108 Pluronic‐stabilized gold nanoparticles (F‐108@TPP‐AuNPs) have been synthesized through a one‐step approach, leading to well‐defined (9.6±1.6 nm) and water‐soluble nanoparticles by microwave heating an aqueous solution of TPP‐Au I Cl in the presence of a Pluronic polymer under basic conditions. TPP release was negligible under physiological conditions, but enhanced significantly at an acidic pH (5.4) mimicking that of a cancer cell. Laser irradiation (532 nm) raised the temperature of an aqueous solution of F‐108@TPP‐AuNPs to 51.7 °C within 5 min, confirming efficient light‐to‐heat conversion capabilities without significant photodegradation. TEM confirmed intracellular localization of F‐108@TPP‐AuNPs in the cytosol, endosomes and lysosomes of HeLa cells. F‐108@TPP‐AuNPs were well tolerated by HeLa cells and zebrafish embryos at ambient temperatures and became toxic upon heat activation, suggesting synergistic interactions between heat and cytotoxic action by TPP.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here